Health Inequality Reduction – making sure enough children are dying in your area

Blackpool CCGs Chief Clinical Officer, Dr Amanda Doyle OBE (pictured centre below)

Ah the good work of her minion Dr Arif Rajpura.

Does anyone have any idea what the “health economy” might be ?

Dr Amanda Doyle OBE has been a GP for 18 years and involved in commissioning for more than a decade.

Her commitment and passion for improving services for patients not only in Blackpool but across the whole health economy has received recognition on a national platform.

In June 2014 she was awarded the OBE in the Queen’s Birthday Honours List for her extraordinary contribution to primary care.

Within weeks of receiving this outstanding honour, Dr Doyle was named as one of the most influential people in the country for her work surrounding health and social care integration.

In the same month she was appointed co-chair of the 26-strong newly formed Board for NHS Clinical Commissioners (NHSCC) – the independent membership organisation which represents all Clinical Commissioning Groups across England

You can read more about Dr Doyle by clicking on the links below.

News about Dr Doyle

A ‘day in the life’ of Dr Amanda Doyle OBE
Chief Clinical Officer of NHS Blackpool Clinical Commissioning Group, Dr Amanda Doyle talks about her role as a GP and commissioner… <read more>

National Recognition for Blackpool’s Chief Clinical Officer
The Chief Clinical Officer of NHS Blackpool Clinical Commissioning Group, Dr Amanda Doyle OBE, has been named as one of the most influential people involved in better coordinating services for patients… <read more>

Our Chief Clinical Officer, Dr Amanda Doyle, Awarded OBE in Queen’s Birthday Honours List
The Chief Clinical Officer of NHS Blackpool Clinical Commissioning Group, Dr Amanda Doyle, has been awarded an OBE in the Queen’s Birthday Honours List… <read more>

Blackpool’s Chief Clinical Officer Named on New Board
Blackpool CCGs Chief Clinical Officer, Dr Amanda Doyle OBE, has been named as Co Chair of NHS Clinical Commissioners (NHSCC)… <read more>

Blackpool GP Takes the Helm in New Look NHS
Black­pool GP Dr Amanda Doyle is the Chief Clin­i­cal Offi­cer for NHS Black­pool Clin­i­cal Com­mis­sion­ing Group (CCG)… <read more>


Director of Public Health

Arif qualified from St Andrews University and Manchester Medical School. Following a period of time in clinical jobs he entered public health training in the North West of England in 1999.

Arif gained his first Consultant in Public Health post in September of 2004, based at Chorley and South Ribble Primary Care Trust. Since August of 2007 Arif has held the position of Director of Public Health of NHS Blackpool and latterly Blackpool Council.

Arif, as the joint appointment across Public Health England and the Council, is responsible for improving the health and reducing health inequalities in an area which has the worst male and the third worst female life expectancy in the country.

Arif is the lead Director of Public Health for alcohol in the North West and has been heavily involved in national lobbying around alcohol policy and particularly minimum unit price. More recently he has been working with North W Directors of Public Health to lobby for a sugar sweetened beverage tax and to curb the marketing influence of unhealthy food companies on children and young people. He is also currently leading a new approach to tackling obesity issues within Blackpool, particularly focussing on the obesogenic environment and helping to make the healthier choice the easier choice.

Arif is also a trainer for trainees in Public Health and has recently been a Part A examiner for the Membership of the Faculty of Public Health.

He has an MBA from Manchester Business School and has recently completed a Postgraduate Certificate in Executive and Business Coaching at Leeds Metropolitan University.

Do these doctors want your children to be dumbed down ?  (TAP – get sick and die younger)

excerpt The Lancet


Neurodevelopmental disabilities, including autism, attention-deficit hyperactivity disorder, dyslexia, and other cognitive impairments, affect millions of children worldwide, and some diagnoses seem to be increasing in frequency. Industrial chemicals that injure the developing brain are among the known causes for this rise in prevalence. In 2006, we did a systematic review and identified five industrial chemicals as developmental neurotoxicants: lead, methylmercury, polychlorinated biphenyls, arsenic, and toluene. Since 2006, epidemiological studies have documented six additional developmental neurotoxicants—manganese, fluoride, chlorpyrifos, dichlorodiphenyltrichloroethane, tetrachloroethylene, and the polybrominated diphenyl ethers. We postulate that even more neurotoxicants remain undiscovered. To control the pandemic of developmental neurotoxicity, we propose a global prevention strategy. Untested chemicals should not be presumed to be safe to brain development, and chemicals in existing use and all new chemicals must therefore be tested for developmental neurotoxicity. To coordinate these efforts and to accelerate translation of science into prevention, we propose the urgent formation of a new international clearinghouse.

Pictured below Mary Ann Cotton

Her choice of poison was arsenic, favoured by murderers down the centuries for largely pragmatic reasons. First, it dissolves in a hot liquid, a cup of tea, for example, so is easy to administer.

Britain's first serial killer, Mary Ann Cotton

Sent in by Ade


3 Responses to “Health Inequality Reduction – making sure enough children are dying in your area”

  1. Aldous says:

    Interesting? This from Jim Stone:

    Zika a virtual proven psyop on Brazil
    BACKGROUND: Brazil does not speak Spanish, Brazil speaks Portuguese. Keep that in mind, and read this from Edu in Brazil:

    Edu wrote:

    I called the virus zica on purpose, because it is slang for “bad luck” in Portuguese. I think “zika” was intended to be a pun also.

    My [Jim Stone’s] response: I think you nailed something with this, but do not think the original name had any specific purpose. I think that whoever is running this psy op took advantage of the name, and the name meaning “bad luck” in Brazil is probably the specific reason why Brazil was chosen. A coincidental name would have a huge psychological impact and perfect deniability. This coincidence needs to be shouted from the rooftops, it is just too perfect.

    As this Zika/Bad Luck thing ‘only’ affects babies/fetuses (a fetus is a baby as far as I’m concerned) in the early development stage of gestation, I can’t help but link it to the Thalidomide outbreak in the late 50’s/early 60’s, where fetuses subjected to Thalidomide were seemingly unaffected if it was taken by the mum-to-be after 42 days of conception.

    There were never any ill effects on the mum-to-be – until birth of course on seeing her hideously deformed baby she had been carrying if Thalidomide was taken before 42 days and certainly within the first 28 days after conception.

    Thalidomide was NO accident and neither is Zika imho.

  2. Aldous says:

    Now come on! This is now getting ridiculous. Is this story for real?

    Zika virus forces India’s Tata Motors to change car’s name

    Charlotte Observer · 3 hrs ago

    The Zika virus has hit India’s Tata Motors, which has decided to rebrand a soon-to-be launched hatchback vehicle which was to have been called “Zica,” [meaning ‘bad luck’ in Portuguese – see above] an abbreviation of “Zippy Car.” [Yeah sure] The car is to be shown for the first time on Wednesday at the Auto Expo 2016 on New Delhi’s outskirts. Tata Motors said in a statement Tuesday that the car will carry the “Zica” nameplate during the exhibition, but a new name will be announced in a few weeks. It said the company decided to rebrand the car to empathize with the hardships caused by the outbreak of the Zika virus in many countries.

Leave a Reply

You must be logged in to post a comment.